Objectives. Outline. Section 1: Interaction between HIV and pregnancy. Effects of HIV on Pregnancy. Section 2: Mother-to-Child-Transmission (MTCT)

Similar documents
treatment during pregnancy and breastfeeding

The New National Guidelines. Feeding in the Context of HIV. Dr. Godfrey Esiru; National PMTCT Coordinator

DEPARTMENT. Treatment Recommendations for. Pregnant and Breastfeeding Women: Critical Issues Consolidated ARV Guidelines. Dr.

HIV Infection in Pregnancy. Francis J. Ndowa WHO RHR/STI

Outline. Aim with PMTCT. How are children transmitted. Prevention of mother-to-child transmission of HIV. How does HIV transmit to children?

CUMULATIVE PERINATAL HIV EXPOSURE, AUSTRALIA. Date

Objectives. Types of HIV Tests. Age Appropriateness of Tests. Breastfeeding and HIV Testing. Why are there different tests for different ages?

Labor & Delivery Management for Women Living with HIV. Pooja Mittal, DO Lisa Rahangdale, MD

Infertility Treatment and HIV

XVII INTERNATIONAL AIDS CONFERENCE MEXICO CITY, 3-8 August 2008 SCALING-UP NATIONAL PMTCT PROGRAM

Family Planning and Sexually Transmitted. Infections, including HIV

TOWARDS ELIMINATION OF MOTHER TO CHILD TRANSMISSION OF HIV

Tunisian recommendations on ART : process and results

Living Positively with HIV

Appendix 1: summary of the modified GRADE system (grades 1A 2D)

The Cumulative Incidence of HIV Infection in HIVexposed Infants with a Birth Weight of 1500g Receiving Breast Milk and Daily Nevirapine

Prevention of Mother to Child Transmission of HIV: Our Experience in South India

To provide you with the basic concepts of HIV prevention using HIV rapid tests combined with counselling.

What will happen to these children?

hiv/aids Programme Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants

HIV and women having children

Integrating prevention & management of STI/HIV/AIDS into reproductive, maternal and newborn health services in China

Linkages between Sexual and Reproductive Health and HIV

Cost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a lowprevalence

Infant feeding in the ARV era. Department of Obstetrics and Gynaecology Faculty of Health Sciences and Tygerberg Hospital

Update on global guidelines. and emerging issues on perinatal HIV prevention. WHO 2013 Consolidated ARV Guidelines

Prevention of Perinatal HIV Transmission

HIV, Women, & Pregnancy

Contraception for Women and Couples with HIV. Knowledge Test

The Pregnancy Journey...

Scaling up priority HIV/AIDS interventions in the health sector

The Global Fund s role as a strategic and responsible investor in HIV/AIDS: Paediatrics and PMTCT

Mother to Child HIV Transmission

PRECONCEPTION COUNSELING

HIV. Transmission modes. Transmission modes in children. Prevention of mother-to-child transmission of HIV. HIV identified in 1983

THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010

Dr Graham P Taylor Reader in Communicable Diseases

Care of the HIV-Exposed Infant

Module 2: Integration of HIV Rapid Testing in HIV Prevention and Treatment Programs

Kingdom of Cambodia Nation Religion King

HIV infection in pregnancy

The elimination equation: understanding the path to an AIDS-free generation

Management of the HIV-Exposed Infant

Positive health, dignity and prevention for women and their babies

PAEDIATRIC HIV INFECTION. Dr Ashendri Pillay Paediatric Infectious Diseases Specialist

Breast Feeding for Women with HIV?

National Guidelines for the Prevention of Mother to Child Transmission of HIV

A Descriptive Study of Outcomes of Interventions to Prevent Mother to Child Transmission of HIV in Lusaka, Zambia

MATERNAL AND CHILD SURVIVAL MEMORANDUM OF CONCERN

Sexual and Reproductive Health and HIV. Dr. Rita Kabra Training course in Sexual and Reproductive Health Research Geneva 2012

Prevention of HIV in infants and young children

Elijah Paintsil, MD, FAAP

Pregnancies amongst adolescents and young women 16% of all births - 19% will have repeat pregnancies before age 20

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014

Dr HM Sebitloane Chief Specialist (Outreach) Dept of O+G NRMSM

PMTCT Max Kroon Mowbray Maternity Hospital Division of Neonatal Medicine School of Child and Adolescent Health University of Cape Town

Obstetrics and HIV An Update. Jennifer Van Horn MD University of Utah

A Call to Action Children The missing face of AIDS

SUMMARY TABLE OF SEXUALLY TRANSMITTED INFECTIONS

Wales Neonatal Network Guideline CARE OF THE BABY WHO HAS BEEN BORN TO AN HIV POSITIVE MOTHER

Figure S1: Overview of PMTCT Options A and B. Prevention of Mother to Child HIV Transmission (PMTCT)

Using new ARVs in pregnancy

Historic Perspective on HIV and TB Research in Pregnant Women

Monitoring of HIV positive mothers and HIV exposed infants in context of Option B+ implementation

CCC ARV Dosing Recommendations for HIV-exposed infants Updated

HIV in Zambia MINISTRY OF HEALTH. Dr Albert Mwango, BScHB, MBChB, MPH National Antiretroviral Program Coordinator,

Anti Retroviral Traitment (ARVs)

UPTAKE OF THE PREVENTION OF MOTHER- TO-CHILD-TRANSMISSION PROGRAMME AT A PRIMARY CARE LEVEL IN SEDIBENG DISTRICT

HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012

Impact of prevention of mother to child transmission (PMTCT) of HIV on positivity rate in Kafanchan, Nigeria

PLANNING INTEGRATED HIV SERVICES AT THE HEALTH CENTRE

LIMPOPO PROVINCIAL MEN S SECTORS/BROTHERS FOR LIFE

Preliminary Outcomes of the PMTCT Option B+ programme in Thyolo District, Malawi

Virtual pediatric HIV elimination in Cambodia: Dr Mean Chhi Vun, Director, National Center for HIV/AIDS Dermatology and STD

SCENARIO. Maternal Medicine- Intrapartum HIV LEARNING OBJECTIVES

HIV IN PREGNANCY PANEL DISCUSSION

Elements of Reproductive Health

Pregnancy and HIV Reviewing the Vertical Transmission Risks 2015 OCN Education Day V Logan Kennedy RN, MN Research Associate and Clinical Nursing

Utilization of HIV and AIDS mother-to-child transmission prevention and babies outcome in Asaba, Nigeria

PMTCT Counseling Support Flipchart

Sexual and Reproductive Health

UNIT 2: FACTS ABOUT HIV/AIDS AND PEOPLE LIVING WITH HIV/AIDS

ANTIRETROVIRAL (ART) DRUG INFORMATION FOR HEALTH CARE PROFESSIONAL

Malaysian Consensus Guidelines on Antiretroviral Therapy Cheng Joo Thye Hospital Raja Permaisuri Bainun Ipoh

Epatite B: fertilità, gravidanza ed allattamento, aspetti clinici e terapeutici. Ivana Maida

INTERPROFESSIONAL PROTOCOL - MUHC

Peter Elyanu 1, Addy Kekitiinwa 2,Rousha Li 1, Mary Paul 3, LY Hwang 1

HIV/AIDS Prenatal Care for HIV+ Mothers. 1. Algorithm for Prenatal Screening & Care (Antepartum)

Scholars Research Library. Changing trends of HIV infection in children with relation to the ongoing PPTCT programme

Prevention of Mother-to-Child Transmission of HIV Infection

Loo k i n g Ba c k, Mo v i n g Fo r wa r d. Im p l e m e n t i n g PMTCT Pr o g r a m s in

Mortality risk factors among HIV-exposed infants in rural and urban Cameroon

Using new ARVs in pregnancy

UPDATE TRAINING ARV TREATMENT GUIDELINES TRAINERS CASE STUDIES & ANSWER GUIDE

1. Africa Centre for Health and Population Studies 2. London School of Hygiene and Tropical Medicine 3. University College London

GLOBAL AIDS MONITORING REPORT

series kids QUESTION ANSWER What are antiretroviral drugs?

Infant feeding and HIV Policy, Evidence and Hospital Challenges

South African goals and national policy

Dr Ade Fakoya Senior HIV Advisor

Transcription:

Objectives Prevention of Mother-to-Child Transmission (PMTCT) Teen Club Community Partners Training Programme By the end of the session participants will be able to: 1. Identify factors affecting the transmission of HIV from mother to child 2. Describe the interventions to prevent the transmission of HIV from mother to child including: Drugs used in PMTCT The PMTCT protocol Outline Interaction between HIV and pregnancy Mother to child transmission (MTCT) Factors affecting MTCT Interventions to prevent MTCT Effects of HIV on Pregnancy Increased risk: Premature delivery Intrauterine Growth Restriction Baby is born smaller than anticipated Stillbirth Infections Baby born dead Sexually transmitted infections, pneumonias, Urinary tract infections, Opportunistic Infections pregnancy Ectopic *NO increased risk of congenital anomalies. Section 1: Interaction between HIV and pregnancy Section 2: Mother-to-Child-Transmission (MTCT) Breast feeders VS NON-breast feeders 1

Timing of Transmission: Targeting Prevention (In an Untreated Breastfeeding Population, Total Transmission Rate is up to 40%) Pregnancy ---------- (5-10%) Timing of Transmission: Targeting Prevention (In an Untreated Non-Breastfeeding Population, Total Transmission Rate is up to 25%) Pregnancy ---------- (5-10%) Delivery ------- (10-15%) Breastfeeding ----- (10-15%) Delivery ------- (10-15%) Section 3: Factors Affecting Transmission 1. Maternal 2. Obstetric 3. Fetal 4. Infant Maternal Factors Increasing the Risk of Transmission High Viral Load Acute infection Advanced Disease Impaired immunologic status (low CD4) Impaired nutritional status High risk behavior (STIs) Obstetric Factors Increasing the Risk of Transmission Prolonged rupture of membranes (> 4 hrs) Intrapartum hemorrhage Invasive obstetrical procedures - Amniocentesis - Invasive fetal monitoring - Forceps Fetal Factors Increasing the Risk of Transmission Prematurity Multiple fetuses First born with increased risk compared to subsequently delivered infant(s). 2

Infant Factors Increasing the Risk of Transmission Breastfeeding Mixed breast feeding Exclusive breast feeding Oral Thrush Prematurity Section 4: Prevention of Mother-to-Child Transmission (PMTCT) 1. Antiretroviral Medications (ARVs) --Treatment (HAART) --Prophylaxis 2. Modifying Obstetric Practices 3. Modifying Infant Feeding Practices ARVs & PMTCT: General Principles ARVs reduce transmission Lower viral load AZT is most studied By itself has PMTCT effects independent of its effect on viral load AZT, NVP, & 3TC considered safest ARVs for MTCT can be administered as part of: 1. Maternal treatment program (HAART) 2. Maternal / infant prophylaxis program HAART & PMTCT: The Botswana National ARV Program (HAART) In Botswana, eligibility for HAART is the same for non-pregnant and pregnant adults: a. CD4 count <250, or b. History of an AIDS-defining illness HAART: Advantages in Pregnancy VERY low transmission rates (<2%). Use of multiple medications decreases the risk of developing resistance. HAART has PMTCT effects independent of its effect on viral load. HAART should be given to ALL pregnant women who qualify for treatment. Prophylaxis & PMTCT : Non-Treatment Programs for the Prevention of Mother-to-Child Transmission Regimens of short course ARVs given to reduce transmission of HIV from a mother to her baby. Such regimens do NOT treat the mother s HIV infection. 3

Botswana National Program for PMTCT PREGNANCY L&D INFANT INTERVENTIONS HAART, if qualifies, or AZT beginning at 28 weeks Mother AZT: NVP: AZT +/- NVP AZT (4w) + NVP Ante-natally (from 28 weeks): 300mg orally q 12 hrs From onset of labour until delivery: 300mg orally q 3 hrs (maximal dose 1500mg) Single-dose (200mg) at onset of labour upon admission to L&D, if not previously on AZT 4 wks Infant AZT: From birth to 4 weeks of life: 4 mg/kg every 12 hours NVP: Single-dose (2mg / kg) immediately after delivery Infant Formula Provision for up to 12 months of life Botswana National Program for PMTCT PMTCT protocol for mothers identified positive only in labor: Single-dose NVP 200mg and AZT q3h per protocol. If infant is premature, AZT dose is 2mg/kg q12h for 4 weeks. If unable to take AZT PO, then administer per NG tube (no IV AZT). If mother is unable to take AZT orally during labor, give IV: 2mg/kg loading dose, followed by 1mg/kg every hour until delivery. Obstetric Practices and PMTCT: Avoid artificial rupture of membranes. Minimize interval between rupture of membranes and delivery. Avoid invasive procedures / instrumented deliveries, whenever possible. - If instruments required, use plastic suction cups. Avoid episiotomy, whenever possible. Perform vaginal cleansing. Infant Feeding Practices and MTCT Infant Feeding Recommendations (1) First Best: Exclusive formula feeding: when clean water, patient education, and safe methods of formula preparation are available. -- Babies in this strategy should NEVER receive breast milk. -- Supplemental liquids (water, juice) and solids (tsabana, cereal) may be introduced at 6 months of age. Infant Feeding Recommendations (2) Second Best: Exclusive Breast feeding -- Mixed breast feeding is NOT recommended at any time. -- In babies completely weaned supplemental liquids (water, juice) and solids (tsabana, cereal) may be introduced at 6 months of age. 4

WHO / UNICEF / UNAIDS (2000) Women should be empowered to make fully informed decisions regarding infant feeding. Women who have access to clean water and formula should be encouraged to exclusively formula feed. Overall, an informed mother is in the best position to decide how to feed her infant(s). Reproductive Choices and HIV National Guidelines recognize the desire of HIV-infected couples (discordant and concordant) to have children: - Couples should be counseled about adoption. - Intercourse for conception should be confined to the fertile period. - Couples must be informed about risks of unprotected sex. ARVs and Potential Impact on Mother-to Child Transmission in Botswana ~40,000 deliveries / year 35% of pregnant women HIV (+) 14,160 babies born to infected mothers / year Without any intervention: 5,660 HIV (+) babies / yr With prophylaxis and exclusive FF: 1770 HIV (+) babies / yr With HAART and exclusive FF: 283 HIV (+) babies / yr The program(s) are available, we just need to see that they get into the community! Empowering the M in MTCT Education / Reinforce benefits of VCT (voluntary counseling & testing) & MTCT Strengthen existing counseling services lay counselors group counseling followed by individual counseling Peer counseling Family / Male involvement Increase access to preventative treatments Increase access to HAART Discussion question! As a community OVC and Palliative care provider: Summary MTCT of HIV-1 can occur during pregnancy, delivery, or through breast milk. Untreated MTCT rates range from 15-40%. What do you consider to be your role in the PMTCT program? Maternal, obstetric, fetal, and infant factors contribute to the risk of MTCT. MTCT can be reduced with the use of ARVs & by modifying obstetric and infant feeding practices. 5

Thank you Thank you to all our Partners 6